845866-72-0 Usage
Uses
Used in Pain Management:
Bremazocine is used as an analgesic agent for the management of chronic pain. Its action on the kappa opioid receptors helps alleviate pain without causing the same level of tolerance and dependence associated with other opioid drugs, making it a safer alternative for long-term pain relief.
Used in Addiction Treatment:
In the field of addiction treatment, Bremazocine is used as a therapeutic agent to help manage withdrawal symptoms and reduce cravings associated with substance abuse. Its ability to modulate the kappa opioid receptors may provide relief from the discomfort and psychological distress experienced during the detoxification process.
Used in Mood Disorders:
Bremazocine is also being studied for its potential use in the treatment of mood disorders, such as depression and anxiety. Its interaction with the kappa opioid receptors may help regulate mood and emotional responses, providing relief from the symptoms of these conditions.
Used in Alcohol Withdrawal Treatment:
In the treatment of alcohol withdrawal symptoms, Bremazocine is used as a supportive therapy to alleviate the discomfort and distress associated with alcohol cessation. Its analgesic and sedative properties, along with its potential to reduce cravings, make it a valuable tool in managing the challenges of alcohol withdrawal.
Check Digit Verification of cas no
The CAS Registry Mumber 845866-72-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,5,8,6 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 845866-72:
(8*8)+(7*4)+(6*5)+(5*8)+(4*6)+(3*6)+(2*7)+(1*2)=220
220 % 10 = 0
So 845866-72-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H15BrN2/c13-10-3-1-9(2-4-10)7-15-8-11-5-12(15)6-14-11/h1-4,11-12,14H,5-8H2
845866-72-0Relevant articles and documents
Synthesis and in Vivo Evaluation of [123I]Melanin-Targeted Agents
Roberts, Maxine P.,Nguyen, Vu,Ashford, Mark E.,Berghofer, Paula,Wyatt, Naomi A.,Krause-Heuer, Anwen M.,Pham, Tien Q.,Taylor, Stephen R.,Hogan, Leena,Jiang, Cathy D.,Fraser, Benjamin H.,Lengkeek, Nigel A.,Matesic, Lidia,Gregoire, Marie-Claude,Denoyer, Delphine,Hicks, Rodney J.,Katsifis, Andrew,Greguric, Ivan
, p. 6214 - 6224 (2015)
This study reports the synthesis, [123I]radiolabeling, and biological profile of a new series of iodinated compounds for potential translation to the corresponding [131I]radiolabeled compounds for radionuclide therapy of melanoma. Ra